drugset / Trial / NCT03916068

Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy

NCT03916068

Phase 2 Terminated 1 enrolled Legacy Health System
RandomizedParallel-groupOpen-labelPrevention

Summary

This study aims to compare patients that receive hyperbaric oxygen or Trental and Vitamin E immediately after completion of radiation therapy to evaluate which treatment best reduces radiation fibrosis.

Timeline

Start
2019-07-01
Primary completion
2023-10-02
Completion
2023-10-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pentoxifylline Small molecule 400 mg

Indications